RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 95 filers reported holding RA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $14,894,000 | -37.7% | 310,218 | -39.1% | 0.01% | -21.4% |
| Q4 2019 | $23,888,000 | +30.4% | 509,009 | -34.3% | 0.01% | +27.3% |
| Q3 2019 | $18,320,000 | +1442.1% | 774,645 | +1861.1% | 0.01% | +1000.0% |
| Q2 2019 | $1,188,000 | +99.3% | 39,500 | +48.5% | 0.00% | – |
| Q1 2019 | $596,000 | +29.6% | 26,600 | +5.1% | 0.00% | – |
| Q4 2018 | $460,000 | +46.0% | 25,300 | +45.4% | 0.00% | – |
| Q3 2018 | $315,000 | +115.8% | 17,400 | +18.4% | 0.00% | – |
| Q2 2018 | $146,000 | -25.1% | 14,700 | +41.3% | 0.00% | – |
| Q2 2017 | $195,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |